Acute Porphyria Drugs

A07EA01 - Prednisolone

Probably not porphyrinogenic
PNP

Rationale
Partly absorbed. Substrate for CYP 3A4, 3A7 and 11B2. Selective inducer of CYP 3A4. Vast experience and several references indicate non-porphyrinogenicity of glucocorticoids.
Chemical description
Glucocorticoid used as clysma in proctitis and ulcerating colitis. About 40% absorbed. Metabolized mainly by CYP 11B2 and 3A4. Selective inducer of CYP 3A4. South African list: use. French list: authorized. Merck Index: safe Kahlman, Bonkowky: Believed to be safe. Tschudy DP, Lamon JM. Porphyria metabolism and the porphyrias, in Bondy PK, Rosenberg LE (eds.): Duncan’s diseases of metabolism. Philadelphia: safe.
IPNet drug reports
Uneventful use reported in 4 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes A07E / A07EA or go back.
References
# Citation details PubMed ID
Other sources
1. French List
Centre Français des Porphyries
2. Porphyrin metabolism and the Porphyrias [Book Chapter]
Tschudy DP, Lamon JM Bondy BK, Rosenberg LE (eds): Duncan's Diseases of Metabolism, Philadelphia, WB Saunders. 1980.
Tradenames

Predenema · Predfoam · Prednisolone · Prednisolone sodium phosphate · Predsol Prednisolon Pred-Clysma · Prednisolon Prednisolon Metilprednisolona Predsol
In cooperation with Ipnet
© Napos 2026
An unhandled error has occurred. Reload 🗙